Evidence map›Paper›PMID 32756470›Full record

ArticlePharmaceutics2020

Synthesis and Ex Vivo Trans-Corneal Permeation of Penetratin Analogues as Ophthalmic Carriers: Preliminary Results.

Silvia Pescina, Marina Sala, Maria Carmina Scala, Patrizia Santi, Cristina Padula, Pietro Campiglia, Carmine Ostacolo, Sara Nicoli

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Protein and polypeptide mediated delivery to the eye.Advanced drug delivery reviews · 2022
    Review
  2. Frontiers in chemistry · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Silvia PescinaDepartment of Food and Drug, University of Parma, Parco Area delle Scienze 27/a, 43124 Parma, Italy.ORCID 0000-0002-6131-4375
Marina SalaDepartment of Pharmacy, University of Salerno, via G. Paolo II 132, Fisciano, 84084 Salerno, Italy.
Maria Carmina ScalaDepartment of Pharmacy, University of Salerno, via G. Paolo II 132, Fisciano, 84084 Salerno, Italy.
Patrizia SantiDepartment of Food and Drug, University of Parma, Parco Area delle Scienze 27/a, 43124 Parma, Italy.ORCID 0000-0001-7601-7894
Cristina PadulaDepartment of Food and Drug, University of Parma, Parco Area delle Scienze 27/a, 43124 Parma, Italy.
Pietro CampigliaDepartment of Pharmacy, University of Salerno, via G. Paolo II 132, Fisciano, 84084 Salerno, Italy.ORCID 0000-0002-1069-2181
Carmine OstacoloDepartment of Pharmacy, University of Napoli Federico II, via D. Montesano 49, 80131 Napoli, Italy.ORCID 0000-0003-3715-8680
Sara NicoliDepartment of Food and Drug, University of Parma, Parco Area delle Scienze 27/a, 43124 Parma, Italy.ORCID 0000-0001-6955-0957
University of Parma · ITUniversity of Salerno · ITUniversity of Naples Federico II · IT

Funding

Ministero dell'Istruzione, dell'Università e della Ricerca PRIN 2017 #20173ZECCM
6 · The paper itself

Abstract

Among enhancing strategies proposed in ocular drug delivery, a rising interest is directed to cell penetrating peptides (CPPs), amino acid short sequences primarily known for their intrinsic ability to cell internalization and, by extension, to cross biological barriers. In fact, CPPs may be considered as carrier for delivering therapeutic agents across biological membranes, including ocular tissues. Several CPPs have been proposed in ophthalmic delivery, and, among them, penetratin (PNT), a 16-amino acids natural peptide, stands out. Therefore, we describe the synthesis via the mimotopic approach of short fluorescently labeled analogues of both PNT and its reversed sequence PNT-R. Their ability to cross ocular membranes was checked ex vivo using freshly explanted porcine cornea. Furthermore, some sequences were studied by circular dichroism. Despite the hydrophilic nature and the relatively high molecular weight (approx. 1.6 kDa), all analogues showed a not negligible trans-corneal diffusion, indicating a partial preservation of penetration activity, even if no sequences reached the noteworthy ability of PNT. It was not possible to find a correlation between structure and corneal penetration ability, and further studies, exploring peptides distribution within corneal layers, for example using imaging techniques, deserve to be performed to figure out a possible difference in intracellular delivery.

Indexed as

CPPenhancerex vivoocular deliverypenetratintrans-corneal

Identifiers

PMID32756470
PMCPMC7466059
OpenAlexW3046686654

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.